Statistical analysis
We investigated whether there was any difference by gender and further whether there was any relation between the clinical findings and gender. Statistical analyses were performed using the Statistical Package for Social Science (SPSS) software, version 15.0 statistical package program (SPSS Inc.; Chicago, IL, USA). Herein, categorical variables are given in numbers or percentages, while continuous variables are expressed as the mean±standard deviation (SD). For the statistical analysis comparing the groups, the paired sample t test was used in the case of parametric data and the Mann-Whitney U test was applied in the case of non-parametric data. Any p<0.05 value was regarded as statistically significant.
Results
Gender and age Out of 329 patients, 199 (60.4%) were males and the male to female ratio was 1.53. The mean age of disease onset was 24.3±8.9 years. Familial history for BD was present in 32 (9.7%) of the patients and a familial history of oral aphtous ulcer was present in 74 (22.5%) of the patients.
While BD initiated at an average age of 25.2 years in males, the females started suffering the disease at the age of 23, on average. The disease, thus, started at an earlier age in females compared to in the males (p<0.05). The average age of diagnosis was 33.1 years in males and 31.4 years in females (p>0.05).
Behçet's disease was found to have an earlier onset in individuals with a positive familial history of oral aphthous ulcer or BD (p=0.03 and p=0.02, respectively).
Initial finding of Behçet's disease
In 95.4% (n=314) of the patients, the finding that was initiated first was repetitive oral aphtous ulcerated lesions, while on the other hand, the initial finding was genital ulcers in 13 patients and ocular involvement in 2 patients.
Clinical findings of Behçet's disease
Oral aphthous ulcers and genital ulcers Oral aphthous ulcers were noted in the entire set of patients. The proportion of genital ulcers was 82% (n=163) in males and 87% (n=113) in females (p=0.213).
Ocular involvement
Ocular involvement was found to exist in 122 (37.1%) of the patients. Ocular involvement was more common in males (p=0.014). Repetitive anterior uveitis, posterior uveitis, retinal vasculitis, optic atrophy, and panuveitis were considered as ocular involvement. We identified that 27 patients had anterior uveitis, 21 had posterior uveitis, 3 had retinal vasculitis, 1 had optic atrophy, and 1 had panuveitis.
HLAB-51 antigen
The HLAB-51 antigen could only be studied in 179 patients and was positive in 79 (44.1%) of them. Out of the positive patients, 38 (38.8%) were males and 41 (50.5%) were females (p=0.103). 
Pathergy testing

Joint involvement
In our sample of patients with BD, 189 (57.4%) had arthritis or arthralgia. Among those patients, 98 (51.8%) were males and 91 (48.1) were females. Joint problems were more frequent in women than in men to a significant extent (p<0.001). Joint involvement was found to be higher in individuals with EN (p=0.02).
Vascular involvement
Among the patients with BD, 109 (33.1%) patients, of whom 89 (81.6%) were males, had vascular involvement. The vascular involvement was significantly higher in males than in females (p<0.001). Thrombophlebitis was detected in 23 (7%) patients, deep vein thrombosis (DVT) in 62 (18.8%), vena cava inferior syndrome (VCIS) in 6 (1.8%), vena kava superior syndrome (VCSS) in 6 (1.8%), Budd-Chiari syndrome in 3 (0.9%), pulmonary artery aneurism in 6 (1.8%), and femoral artery aneurism in 3 (0.9%).
Neurological involvement
A total of 25 (7.6%) patients, comprising 17 males and 8 females, had Neuro-Behçet's disease (with vascular or parenchymal involvement). This difference by gender was not significant (p=0.409). When it comes to headache, 150 (45.6%) patients had headache, 78 (52%) of whom were females. Headache was more common in women, exhibiting a significant difference (p<0.001).
The breakdown of clinical findings according to the genders is given in Table 1 .
Discussion
Behçet's Disease is a multi-system vasculitis affecting young adults. Gender has an impact on its clinical findings and prognosis. A review of (3, 5, 6, 9) . In our study, the age of onset was 24.3 years. The differences may arise from the different patient inclusion criteria and regional variances. Although the literature does not indicate any difference by gender in the age of disease onset, we determined an earlier onset of BD in our female patients.
Despite the reason behind BD remaining elusive, the importance of familial history is highlighted in the literature concerning the genetic predisposition (12) . A positive familial history in BD has been reported to be as high as 15.4% in an epidemiological study by Bang et al. (3) in Korea, while it as at the level of 3.9% in Iran and 2% in Japan; and in Turkey, it was determined to be 7.3% in the analysis of Gürler et al. (7), 13 .3% in the analysis of Ugurlu et al. (8) , and finally, 9.7% in our patients (4, 10) . Patients with BD also have an increased frequency of oral aphthous ulcers independent of a familial history of BD. In our study, the frequency of occurrence of oral aphthous ulcers in the family was 22.5%. This figure is close to the proportion detected in Iran, i.e., 28.5-29.2% (10). Moreover, we identified an earlier onset in patients who have a positive familial history of BD and likewise in patients who have a positive familial history of oral aphthous ulcers, a conclusion that was not mentioned in other studies.
As per the 1990 International Study Group, all patients should have recurrent oral aphthous ulcers so that they can be diagnosed to have BD (11) . Indeed, all of our patients had an oral aphthous ulcer. Indeed, in most of the cases, the initial finding of the patients is established to be oral aphthous ulcer. Consistently, the initial finding of BD was oral aphthous ulcer in 95.4% of our patients. The initial finding was rarely genital ulcers and ocular involvement, which is in line with the available literature (3, 4, 8) .
There are studies in the literature that imply a difference in clinical findings between male and female patients, but there are also other studies that fail to demonstrate such a difference (3, 5, 7-10).
Ocular involvement ranged between 32.9% and 58.1% in the evaluated studies (5, 8) . Ocular involvement in our patients was similar to that in the literature, and males had a greater rate of ocular involvement, similar to the study of Ugurlu et al. (8) .
In another study conducted in Turkey, HLA-B51 antigen positivity frequency was, similarly to our study, stated to be around 44% (8) . The frequency of a positive pathergy test result varied among the studies. Certain studies concluded an elevated level of positive results in males (10). Gürler et al. (7) reported 56.8% of the patients were positive in the pathergy test, whereas Ugurlu et al. (8) stated this proportion as 40.8%, while a study from Japan reported a figure of 43.8% (4). However, there was no difference among our male and female patients in terms of positive pathergy test results.
In their study, Ugurlu et al. (8) reported a higher proportion of EN and joint involvement in women. Despite EN being found to occur more commonly in our female patients, as also described by the current literature, this difference was not significant. The higher occurrence of joint involvement in females, on the other hand, was at a significant extent. Some clinical features of BD tend to manifest jointly (2). Although the concurrence of joint involvement and papulopustular lesions has been defined in the literature, we identified joint involvement to be more common in those with EN.
In BD, the vascular involvement is not only a widespread involvement type but is also determinative in disease prognosis. The prognosis of BD in male patients becomes worse particularly in the event of ocular involvement, neurological involvement, or vascular involvement (2) . In agreement with the study of Ugurlu et al. (8), we found vascular involvement and ocular involvement to be more common in males. In their study, Davitchi et al. (10) could not specify a strong correlation between the major symptoms of BD and gender, yet the strongest correlation was attributed between the vascular involvement and male gender. Ugurlu et al. (8) found that disease severity and prognosis were worse in men at BD patients. The aim of our study was not to determine the severity of the disease or prognosis; however, we did find that vascular and ocular involvement occurred more common in men in our study. From a gender-oriented point of view, certain studies demonstrate a higher prevalence of neurological involvement in males (8) . Although neurological involvement was more common in males in our study as well, the difference was not significant. Actually, the most common manifestation of neurological involvement in BD is headache (13) . Our patients suffered headache at a proportion of 45.6%, which corresponds to a higher figure given the proportions in the literature, and, in compliance with the literature data, headache was more commonly encountered in women than in men (5). It is difficult to speculate whether or not headache has a direct association with the BD, as it has not been classified.
The key limitation of our study was its retrospective design. Another main limitation was the fact that neither HLA-B51 antigen nor pathergy testing could be performed on all our patients.
In conclusion, the clinical features of BD may vary between the genders. Variations exist in the results depending on the size of the examined population, the department where the study was conducted, patient inclusion criteria, and also the region where the patients are living. In particular, similar to the previous literature, vascular involvement and ocular involvement were found to be more common in our male patients, whereas joint involvement was detected to occur more frequently in female patients. During the follow-up of patients with BD, these results should be kept in mind regarding the monitoring and prognosis of the disease.
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